Grant

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to...

Sponsored by Momenta Pharmaceuticals

$92.8K Funding

1 People

External

Related Topics

clinical trial, pharmacokinetics, pharmacodynamics, safety, efficacy

People

Katalin Scherer
Principal Investigator (PI)
Neurology﹒Professor